World News | Combinations of Sputnik V Component with Three Other Vaccines Demonstrates Favourable Results: RDIF Study
Get latest articles and stories on World at LatestLY. The Russian Direct Investment Fund on Wednesday announced that combination of the first component of Sputnik V vaccine with vaccines by AstraZeneca, Sinopharm, and Moderna demonstrated favorable results.
Moscow [Russia] August 5 (ANI): The Russian Direct Investment Fund on Wednesday announced that combination of the first component of Sputnik V vaccine with vaccines by AstraZeneca, Sinopharm, and Moderna demonstrated favorable results.
A study was conducted in Argentina, in which, the heterogeneous boosting approach ('vaccine cocktail' using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component) was at the core of Sputnik V, the world's first registered vaccine against coronavirus. With this approach proving successful in creating a longer and more durable immunity against the coronavirus, a statement from RDIF said.
Also Read | UK Govt Expands COVID-19 Vaccination Programme for Adolescents Aged 16 and 17 Years.
"RDIF took the lead in initiating partnerships with other vaccine producers to conduct joint studies of a combination of the first component of Sputnik V with foreign vaccines," the statement said.
To date, the of 121 volunteers corresponding to the Sputnik V combination groups were analyzed in the these regimens; Sputnik Light/AstraZeneca, Sputnik Light/Moderna, Sputnik Light/Sinopharm, Sputnik Light/Sputnik Light compared to control group Sputnik V 1 Comp./Sputnik V 2 Comp.
Also Read | Muharram 2021 Date in Iran: When Is Ashura and Moon Sighting for for the First Islamic Month?.
Meanwhile, Kirill Dmitriev, CEO of RDIF also remarked on the successful trial and said "RDIF is the first country to offer vaccine cooperation to other producers to conduct joint mix and match studies. This approach is the most promising one to fight the pandemic and new strains of coronavirus emerging around the world."
The Sputnik Light vaccine can be effectively used in combination with other vaccines which is proven by studies in Argentina and other countries. RDIF is ready to partner with other producers for further 'mix & match' studies in other parts of the world," Dmitriev added. (ANI)
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)